-
IntroducedNov 30, 2021
-
Passed Senate
-
Passed House
-
Signed into Law
Regulation of Compounded Drug Products; Requiring the Surgeon General, on behalf of the Department of Health, to sign and become a party to the United States Food and Drug Administration’s Memorandum of Understanding Addressing Certain Distributions of Compounded Human Drug Products; requiring certain pharmacy permittees to annually report information to the National Association of Boards of Pharmacy’s information sharing network as required by the memorandum, etc.
Last Action See all actions
Senate • Mar 14, 2022: Died in Health Policy
Latest Bill Text See all bill texts
Official Summary/Bill Text
Comments on SB 1096
Tweets
Whip Lists
Sponsors
- Brodeurprimary
Votes
Actions
- Mar 14, 2022 | Senate
- Died in Health Policy
- Mar 12, 2022 | Senate
- Indefinitely postponed and withdrawn from consideration
- Jan 11, 2022 | Senate
- Introduced
- Dec 13, 2021 | Senate
- Referred to Health Policy; Regulated Industries; Rules
- Nov 30, 2021 | Senate
- Filed
Bill Texts
Documents